Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVRP in Chronic Otitis Media
NCT04761562Phase 3Unknown
- Sponsor
- University Medical Centre Ljubljana
- Start
- Feb 2021
- Primary completion
- Sep 2023
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of platelet- and extracellular vesicle-rich plasma in chronic otitis media (COM) and tympanic membrane perforation (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoints: Change of tympanic membrane perforation size at 6 months and Change in Chronic Otitis Media Questionnaire 12 score at 6 months. Status: unknown.
02
Drugs
platelet- and extracellular vesicle-rich plasma
03
Conditions
chronic otitis media (COM)tympanic membrane perforation
Beyond the preview
Go deeper on NCT04761562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04761562.